Kidney biopsies after liver transplant for new kidney problems
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies kidney biopsies in people who had a liver transplant and then developed new signs of kidney damage. The goal is to better understand what’s causing the problem and how to guide next steps.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You had a liver transplant in the past
- In the last period, you developed new kidney issues such as high urine protein (or worsening kidney function), like eGFR below 60 on two checks, or creatinine rising by at least 50%
- You had a kidney (renal) biopsy within the last 3 months
- You can sign the informed consent form
- You have not had a kidney transplant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
This study looks at kidney tissue from patients having a liver transplant to understand and improve treatment for a kidney problem called hepatorenal syndrome. It may help doctors find better ways to protect kidney function after transplant.
This study will collect blood samples from people having a kidney biopsy or a kidney transplant to look for biomarkers (biological signs) that can give doctors more information about kidney health. Participating may help doctors better understand and treat kidney disease in the future.
This study tests whether a special blood test can help monitor your new kidney after transplant. It may help doctors spot problems earlier and improve kidney health.
This study looks at kidney transplant patients to better predict long-term outcomes by examining small samples of kidney tissue (biopsies). It may help doctors understand why some transplants succeed and others don't, potentially improving care.
This study collects blood and leftover donor samples from kidney transplant recipients who need a biopsy. The goal is to improve monitoring after transplant.
Hear when a new Liver Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.